149 related articles for article (PubMed ID: 25219463)
1. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.
Alonso-Alconada L; Santacana M; Garcia-Sanz P; Muinelo-Romay L; Colas E; Mirantes C; Monge M; Cueva J; Oliva E; Soslow RA; Lopez MA; Palacios J; Prat J; Valls J; Krakstad C; Salvesen H; Gil-Moreno A; Lopez-Lopez R; Dolcet X; Moreno-Bueno G; Reventos J; Matias-Guiu X; Abal M
Int J Cancer; 2015 Apr; 136(8):1863-73. PubMed ID: 25219463
[TBL] [Abstract][Full Text] [Related]
2. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
3. Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas.
Herrero C; Brea J; Pérez-Díaz A; Cuadrado E; Ferreño N; Moiola CP; Colás E; Gil-Moreno A; López-López R; Loza MI; Abal M; Alonso-Alconada L
Biomed Pharmacother; 2021 Aug; 140():111744. PubMed ID: 34049223
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
[TBL] [Abstract][Full Text] [Related]
5. Proteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of endometrial cells in human adenomyosis.
Zhou S; Yi T; Liu R; Bian C; Qi X; He X; Wang K; Li J; Zhao X; Huang C; Wei Y
Mol Cell Proteomics; 2012 Jul; 11(7):M112.017988. PubMed ID: 22493182
[TBL] [Abstract][Full Text] [Related]
6. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and diagnostic significance of annexin A2 in colorectal cancer.
Yang T; Peng H; Wang J; Yang J; Nice EC; Xie K; Huang C
Colorectal Dis; 2013 Jul; 15(7):e373-81. PubMed ID: 23489866
[TBL] [Abstract][Full Text] [Related]
9. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.
Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364
[TBL] [Abstract][Full Text] [Related]
10. Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.
Brennan DJ; Hackethal A; Mann KP; Mutz-Dehbalaie I; Fiegl H; Marth C; Obermair A
BMC Cancer; 2015 Feb; 15():33. PubMed ID: 25655024
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Annexin A2 as a novel diagnostic serum biomarker for lung cancer.
Yang J; Yang F; Nie J; Zou X; Tian H; Qin Y; Liu C
Cancer Biomark; 2015; 15(2):205-11. PubMed ID: 25519022
[TBL] [Abstract][Full Text] [Related]
12. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
[TBL] [Abstract][Full Text] [Related]
14. Circulating annexin A2 as a biomarker in patients with pancreatic cancer.
Karabulut M; Afsar CU; Serilmez M; Karabulut S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S110-S115. PubMed ID: 33380663
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
Jiang T; Huang L; Zhang S
BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
[TBL] [Abstract][Full Text] [Related]
16. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
17. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients.
Sartori E; Pasinetti B; Carrara L; Gambino A; Odicino F; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S241-7. PubMed ID: 17826824
[TBL] [Abstract][Full Text] [Related]
18. The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer.
Nicklin J; Janda M; Gebski V; Jobling T; Land R; Manolitsas T; McCartney A; Nascimento M; Perrin L; Baker JF; Obermair A;
Int J Cancer; 2012 Aug; 131(4):885-90. PubMed ID: 21918977
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer.
Staff AC; Trovik J; Eriksson AG; Wik E; Wollert KC; Kempf T; Salvesen HB
Clin Cancer Res; 2011 Jul; 17(14):4825-33. PubMed ID: 21616994
[TBL] [Abstract][Full Text] [Related]
20. Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?
De Bruyn C; Baert T; Van den Bosch T; Coosemans A
Curr Oncol Rep; 2020 Jan; 22(2):12. PubMed ID: 31997106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]